Moujalled, Diane
White, Anthony R.
Funding for this research was provided by:
Alzheimer's Australia Dementia Research Foundation
Motor Neurone Disease Research Institute of Australia
Australian Research Council
National Health and Medical Research Council
Article History
First Online: 19 February 2016
Compliance with Ethical Standards
:
: DM is supported by an Alzheimer’s Australia Dementia Research fellowship (AADRF) and funding from the Motor Neuron Disease Research Institute of Australia (MNDRIA). ARW is supported by an Australian Research Council Future Fellowship and The National Health and Medical Research Council of Australia.
: Patent protection has previously been sought by the University of Melbourne for the use of bis(thiosemicarbazones) for treatment of diseases. ARW is a co-inventor on the patent application PCT/AU2007/001792 that is the subject of a commercialization contract between the University and a private company. The company has neither funded nor contributed to research described in this manuscript. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. No writing assistance was utilized in the production of this manuscript.